Vext Science, Inc. VEXTF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 52.91M | 50.68M | 51.97M | 51.37M | 47.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.91M | 50.68M | 51.97M | 51.37M | 47.83M |
| Cost of Revenue | 34.30M | 31.15M | 34.27M | 36.91M | 34.58M |
| Gross Profit | 18.62M | 19.54M | 17.70M | 14.45M | 13.26M |
| SG&A Expenses | 20.12M | 19.07M | 18.33M | 17.24M | 16.22M |
| Depreciation & Amortization | 4.05M | 3.95M | 4.12M | 3.98M | 3.84M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.46M | 54.16M | 56.71M | 58.14M | 54.64M |
| Operating Income | -5.55M | -3.48M | -4.75M | -6.77M | -6.81M |
| Income Before Tax | -13.90M | -12.63M | -12.30M | -15.22M | -13.36M |
| Income Tax Expenses | 2.75M | 1.76M | 3.25M | 2.78M | 3.30M |
| Earnings from Continuing Operations | -16.65 | -14.39 | -15.56 | -18.00 | -16.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.65M | -14.39M | -15.56M | -18.00M | -16.66M |
| EBIT | -5.55M | -3.48M | -4.75M | -6.77M | -6.81M |
| EBITDA | 8.98M | 11.08M | 10.16M | 8.15M | 7.98M |
| EPS Basic | -0.07 | -0.06 | -0.06 | -0.07 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| EPS Diluted | -0.07 | -0.06 | -0.06 | -0.07 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 990.76M | 990.67M | 990.57M | 990.37M | 990.13M |
| Average Diluted Shares Outstanding | 990.76M | 990.67M | 990.57M | 990.37M | 990.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |